Report Detail
Global Space Medicine Market Growth (Status and Outlook) 2023-2029
- RnM4502242 |
- 18 January, 2023 |
- Global |
- 101 Pages |
- LPI(LP Information) |
- Medical Industry
The global Space Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Space Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Space Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Space Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Space Medicine players cover Space Pharma, Biogen, Amgen, Merck, Eli Lilly and Company, Sanofi, AstraZeneca, Novartis and Kernal Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Newest research report, the “Space Medicine Industry Forecast” looks at past sales and reviews total world Space Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Space Medicine sales for 2023 through 2029. With Space Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Space Medicine industry.
This Insight Report provides a comprehensive analysis of the global Space Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Space Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Space Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Space Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Space Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Space Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Private Aerospace Service
Non-Private Aerospace Service
Segmentation by application
Oncology
Regeneration Medicine
Neuro Biology
Microbiology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Space Pharma
Biogen
Amgen
Merck
Eli Lilly and Company
Sanofi
AstraZeneca
Novartis
Kernal Biologics
RevBio, Inc
Pluristem
MEDES
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Space Medicine Market Size 2018-2029
- 2.1.2 Space Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Space Medicine Segment by Type
- 2.2.1 Private Aerospace Service
- 2.2.2 Non-Private Aerospace Service
- 2.3 Space Medicine Market Size by Type
- 2.3.1 Space Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Space Medicine Market Size Market Share by Type (2018-2023)
- 2.4 Space Medicine Segment by Application
- 2.4.1 Oncology
- 2.4.2 Regeneration Medicine
- 2.4.3 Neuro Biology
- 2.4.4 Microbiology
- 2.4.5 Others
- 2.5 Space Medicine Market Size by Application
- 2.5.1 Space Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Space Medicine Market Size Market Share by Application (2018-2023)
3 Space Medicine Market Size by Player
- 3.1 Space Medicine Market Size Market Share by Players
- 3.1.1 Global Space Medicine Revenue by Players (2018-2023)
- 3.1.2 Global Space Medicine Revenue Market Share by Players (2018-2023)
- 3.2 Global Space Medicine Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Space Medicine by Regions
- 4.1 Space Medicine Market Size by Regions (2018-2023)
- 4.2 Americas Space Medicine Market Size Growth (2018-2023)
- 4.3 APAC Space Medicine Market Size Growth (2018-2023)
- 4.4 Europe Space Medicine Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Space Medicine Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Space Medicine Market Size by Country (2018-2023)
- 5.2 Americas Space Medicine Market Size by Type (2018-2023)
- 5.3 Americas Space Medicine Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Space Medicine Market Size by Region (2018-2023)
- 6.2 APAC Space Medicine Market Size by Type (2018-2023)
- 6.3 APAC Space Medicine Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Space Medicine by Country (2018-2023)
- 7.2 Europe Space Medicine Market Size by Type (2018-2023)
- 7.3 Europe Space Medicine Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Space Medicine by Region (2018-2023)
- 8.2 Middle East & Africa Space Medicine Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Space Medicine Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Space Medicine Market Forecast
- 10.1 Global Space Medicine Forecast by Regions (2024-2029)
- 10.1.1 Global Space Medicine Forecast by Regions (2024-2029)
- 10.1.2 Americas Space Medicine Forecast
- 10.1.3 APAC Space Medicine Forecast
- 10.1.4 Europe Space Medicine Forecast
- 10.1.5 Middle East & Africa Space Medicine Forecast
- 10.2 Americas Space Medicine Forecast by Country (2024-2029)
- 10.2.1 United States Space Medicine Market Forecast
- 10.2.2 Canada Space Medicine Market Forecast
- 10.2.3 Mexico Space Medicine Market Forecast
- 10.2.4 Brazil Space Medicine Market Forecast
- 10.3 APAC Space Medicine Forecast by Region (2024-2029)
- 10.3.1 China Space Medicine Market Forecast
- 10.3.2 Japan Space Medicine Market Forecast
- 10.3.3 Korea Space Medicine Market Forecast
- 10.3.4 Southeast Asia Space Medicine Market Forecast
- 10.3.5 India Space Medicine Market Forecast
- 10.3.6 Australia Space Medicine Market Forecast
- 10.4 Europe Space Medicine Forecast by Country (2024-2029)
- 10.4.1 Germany Space Medicine Market Forecast
- 10.4.2 France Space Medicine Market Forecast
- 10.4.3 UK Space Medicine Market Forecast
- 10.4.4 Italy Space Medicine Market Forecast
- 10.4.5 Russia Space Medicine Market Forecast
- 10.5 Middle East & Africa Space Medicine Forecast by Region (2024-2029)
- 10.5.1 Egypt Space Medicine Market Forecast
- 10.5.2 South Africa Space Medicine Market Forecast
- 10.5.3 Israel Space Medicine Market Forecast
- 10.5.4 Turkey Space Medicine Market Forecast
- 10.5.5 GCC Countries Space Medicine Market Forecast
- 10.6 Global Space Medicine Forecast by Type (2024-2029)
- 10.7 Global Space Medicine Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Space Pharma
- 11.1.1 Space Pharma Company Information
- 11.1.2 Space Pharma Space Medicine Product Offered
- 11.1.3 Space Pharma Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Space Pharma Main Business Overview
- 11.1.5 Space Pharma Latest Developments
- 11.2 Biogen
- 11.2.1 Biogen Company Information
- 11.2.2 Biogen Space Medicine Product Offered
- 11.2.3 Biogen Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Biogen Main Business Overview
- 11.2.5 Biogen Latest Developments
- 11.3 Amgen
- 11.3.1 Amgen Company Information
- 11.3.2 Amgen Space Medicine Product Offered
- 11.3.3 Amgen Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Amgen Main Business Overview
- 11.3.5 Amgen Latest Developments
- 11.4 Merck
- 11.4.1 Merck Company Information
- 11.4.2 Merck Space Medicine Product Offered
- 11.4.3 Merck Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Merck Main Business Overview
- 11.4.5 Merck Latest Developments
- 11.5 Eli Lilly and Company
- 11.5.1 Eli Lilly and Company Company Information
- 11.5.2 Eli Lilly and Company Space Medicine Product Offered
- 11.5.3 Eli Lilly and Company Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Eli Lilly and Company Main Business Overview
- 11.5.5 Eli Lilly and Company Latest Developments
- 11.6 Sanofi
- 11.6.1 Sanofi Company Information
- 11.6.2 Sanofi Space Medicine Product Offered
- 11.6.3 Sanofi Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Sanofi Main Business Overview
- 11.6.5 Sanofi Latest Developments
- 11.7 AstraZeneca
- 11.7.1 AstraZeneca Company Information
- 11.7.2 AstraZeneca Space Medicine Product Offered
- 11.7.3 AstraZeneca Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 AstraZeneca Main Business Overview
- 11.7.5 AstraZeneca Latest Developments
- 11.8 Novartis
- 11.8.1 Novartis Company Information
- 11.8.2 Novartis Space Medicine Product Offered
- 11.8.3 Novartis Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Novartis Main Business Overview
- 11.8.5 Novartis Latest Developments
- 11.9 Kernal Biologics
- 11.9.1 Kernal Biologics Company Information
- 11.9.2 Kernal Biologics Space Medicine Product Offered
- 11.9.3 Kernal Biologics Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Kernal Biologics Main Business Overview
- 11.9.5 Kernal Biologics Latest Developments
- 11.10 RevBio, Inc
- 11.10.1 RevBio, Inc Company Information
- 11.10.2 RevBio, Inc Space Medicine Product Offered
- 11.10.3 RevBio, Inc Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 RevBio, Inc Main Business Overview
- 11.10.5 RevBio, Inc Latest Developments
- 11.11 Pluristem
- 11.11.1 Pluristem Company Information
- 11.11.2 Pluristem Space Medicine Product Offered
- 11.11.3 Pluristem Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Pluristem Main Business Overview
- 11.11.5 Pluristem Latest Developments
- 11.12 MEDES
- 11.12.1 MEDES Company Information
- 11.12.2 MEDES Space Medicine Product Offered
- 11.12.3 MEDES Space Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 MEDES Main Business Overview
- 11.12.5 MEDES Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Space Medicine. Industry analysis & Market Report on Space Medicine is a syndicated market report, published as Global Space Medicine Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Space Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
